Evidence-Based Self-management In Multiple Sclerosis (EBSIMS). A multi
Evidence-Based Self-management In Multiple Sclerosis (EBSIMS). A multi-centre, randomised controlled trial to investigate the effects of a structured educational programme on relapse management in Multiple Sclerosis.
What it found
A paper reports the results; we have not read it yet. See Papers below.
What it measured
Main measures
Percentage of relapses without steroid-treatment or with oral steroid-treatment within 2 years of follow-up.
Relapses
Other measures (1)
1. Time to initiation of treatment 2. Overall costs 3. Characteristics of steroid-treatments 4. Changes in autonomy preferences 5. Protection motivation 6. Quality of life 7. Relapse severity 8. Adverse treatment effects 9. Other clinical variables
RelapsesQuality of life (reported by participants)
Who could take part
Relapsing MS
Show the full criteria
Inclusion criteria
Inclusion: Patients with relapsing-remitting Multiple Sclerosis (MS), with at least 2 relapses in the last 24 months or at least one relapse in the last 12 months. Exclusion: Patients with severe cognitive deficits or pregnancy
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Not provided at time of registration
Papers
Results
results
Loading reviews and guidelines…
History
Started
Apr 2003
Finished
Apr 2005